GlassScriptPhysician profile
Raymond Schulte
NPI 1659346054
$439.50
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $55.00 · 2021: $16.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $160.81 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.08 | 2019 | |
| Pfizer INC. | $36.73 | 2019 | |
| Karl Storz Endoscopy-America | $36.32 | 2020-2021 | |
| Astellas Pharma US INC | $28.59 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.91 | 2019 | |
| Minerva Surgical, INC | $20.20 | 2020 | |
| Medtronic Vascular, INC. | $19.10 | 2019 | |
| Duchesnay USA Incorporated | $14.33 | 2019 | |
| Allergan, INC. | $13.22 | 2019 | |
| Therapeuticsmd, INC. | $12.24 | 2019 | |
| Olympus America INC. | $11.70 | 2019 | |
| Daiichi Sankyo INC. | $11.31 | 2019 | |
| Davol INC. | $10.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Schulte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.